February 17, 2026 / Sciad Communications / Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou ...

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends ...

BioLife Solutions, Inc. , a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2025 fourth quarter and full year ...

The Vilcek Foundation is now accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science through May 4, 2026. These $50,000 cash awards are given each year to three ...

Cryoport, Inc. ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the ...

Experts attending WHX Labs today highlighted the emerging technologies that are redefining molecular diagnostics ...

Among an upended global health order, medical innovation pushes forward. Read how TIME chose the list of doctors, scientists ...

Britain’s farmers and agtech industries are in open revolt over Labour’s attempt to ram through a food and farm deal with the EU that threatens to do serious harm.

Kerstin Wolff of Maiwald explains how the EU’s provisional agreement on plants generated by new genomic techniques divides them into two categories, opening the market while preserving patent and regu ...